Theriva Biologics's market cap is currently ―. The company's EPS TTM is $-1.145; its P/E ratio is -0.39; Theriva Biologics is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -5.91M	$ -3.83M	$ -5.44M	$ -5.17M	$ -7.33M
EBITDA	$ -5.87M	$ -3.80M	$ -5.41M	$ -5.14M	$ -7.30M
Net Income Common Stockholders	$ -5.45M	$ -3.30M	$ -5.10M	$ -4.48M	$ 1.48M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 23.18M	$ 31.16M	$ 34.25M	$ 36.08M	$ 41.79M
Total Assets	$ 55.22M	$ 61.55M	$ 65.45M	$ 67.56M	$ 71.86M
Total Debt	$ 2.15M	$ 2.22M	$ 2.36M	$ 2.46M	$ 1.68M
Net Debt	$ -21.02M	$ -28.94M	$ -31.89M	$ -33.61M	$ -40.10M
Total Liabilities	$ 15.52M	$ 17.66M	$ 17.70M	$ 19.31M	$ 17.30M
Stockholders Equity	$ 36.96M	$ 41.15M	$ 45.02M	$ 47.85M	$ 51.83M
Cash Flow	-
Free Cash Flow	$ -6.60M	$ -3.08M	$ -4.37M	$ -5.75M	$ -5.46M
Operating Cash Flow	$ -6.54M	$ -2.95M	$ -4.36M	$ -5.75M	$ -5.37M
Investing Cash Flow	$ -56.00K	$ -129.00K	$ 424.00K	$ 127.00K	$ -91.00K
Financing Cash Flow	$ -1.46M	$ 1.00K	$ 2.14M	$ -55.00K	$ -3.29M

Currency in USD

Theriva Biologics Earnings and Revenue History

Income Statement >

Theriva Biologics Debt to Assets

Balance Sheet >

Theriva Biologics Cash Flow

Cash Flow >

Theriva Biologics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing